Since it was first described as a prostate specific protein and a potential marker for PCa, the level of PSA (prostate specific antigen) protein in blood has become the most commonly used molecular marker for screening, diagnosis and management of PCa and indeed is the most widely used screening marker for any cancer [22]. This evidence concerns the gene KLK3 and cancer.